Connection

CHARLES CLEELAND to Female

This is a "connection" page, showing publications CHARLES CLEELAND has written about Female.
Connection Strength

1.336
  1. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269.
    View in: PubMed
    Score: 0.020
  2. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). Qual Life Res. 2018 Dec; 27(12):3229-3241.
    View in: PubMed
    Score: 0.019
  3. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Support Care Cancer. 2019 Mar; 27(3):1021-1028.
    View in: PubMed
    Score: 0.019
  4. The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials. Eur J Pain. 2018 03; 22(3):565-571.
    View in: PubMed
    Score: 0.018
  5. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017 06; 158(6):1108-1112.
    View in: PubMed
    Score: 0.017
  6. Validation of the Persian Version of the Brief Pain Inventory (BPI-P) in Chronic Pain Patients. J Pain Symptom Manage. 2017 07; 54(1):132-138.e2.
    View in: PubMed
    Score: 0.017
  7. Validity and reliability of a Turkish Brief Pain Inventory Short Form when used to evaluate musculoskeletal pain. J Back Musculoskelet Rehabil. 2017; 30(2):229-233.
    View in: PubMed
    Score: 0.017
  8. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. J Pain Symptom Manage. 2016 11; 52(5):744-751.
    View in: PubMed
    Score: 0.016
  9. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. Eur J Cancer. 2016 11; 67:83-90.
    View in: PubMed
    Score: 0.016
  10. Patient-Reported Symptom Interference as a Measure of Postsurgery Functional Recovery in Lung Cancer. J Pain Symptom Manage. 2016 12; 52(6):822-831.
    View in: PubMed
    Score: 0.016
  11. Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer. Support Care Cancer. 2016 08; 24(8):3557-65.
    View in: PubMed
    Score: 0.016
  12. Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer. Oncology. 2016; 90(3):127-35.
    View in: PubMed
    Score: 0.016
  13. Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain. 2015 Oct; 16(10):1032-43.
    View in: PubMed
    Score: 0.015
  14. Symptom management of gynecologic cancers: refocusing on the forest. Gynecol Oncol. 2015 Mar; 136(3):413-4.
    View in: PubMed
    Score: 0.015
  15. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Cancer. 2015 Apr 01; 121(7):1138-46.
    View in: PubMed
    Score: 0.014
  16. The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73.
    View in: PubMed
    Score: 0.014
  17. Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study. Breast. 2014 Dec; 23(6):763-9.
    View in: PubMed
    Score: 0.014
  18. Symptom burden in hematologic malignancies. Blood. 2014 Jun 12; 123(24):3686-7.
    View in: PubMed
    Score: 0.014
  19. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014 Feb 01; 120(3):425-32.
    View in: PubMed
    Score: 0.014
  20. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014 Mar 01; 20(5):1366-74.
    View in: PubMed
    Score: 0.014
  21. Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors. Cancer. 2014 Feb 01; 120(3):442-50.
    View in: PubMed
    Score: 0.013
  22. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013 Dec 15; 119(24):4333-40.
    View in: PubMed
    Score: 0.013
  23. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8.
    View in: PubMed
    Score: 0.013
  24. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manage. 2013 Dec; 46(6):837-45.
    View in: PubMed
    Score: 0.013
  25. Authors' reply to Tendas et al. J Pain Symptom Manage. 2013 Apr; 45(4):e3-4.
    View in: PubMed
    Score: 0.013
  26. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9.
    View in: PubMed
    Score: 0.013
  27. Anastrozole-associated joint pain and other symptoms in patients with breast cancer. J Pain. 2013 Mar; 14(3):290-6.
    View in: PubMed
    Score: 0.013
  28. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer. 2013 Feb 15; 119(4):832-8.
    View in: PubMed
    Score: 0.012
  29. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012 Aug; 44(2):168-80.
    View in: PubMed
    Score: 0.012
  30. Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. J Pain. 2012 Jun; 13(6):564-70.
    View in: PubMed
    Score: 0.012
  31. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012 Jun 01; 30(16):1980-8.
    View in: PubMed
    Score: 0.012
  32. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun. 2012 Jul; 26(5):699-705.
    View in: PubMed
    Score: 0.012
  33. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65.
    View in: PubMed
    Score: 0.011
  34. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer. 2011 Jun 15; 117(12):2779-90.
    View in: PubMed
    Score: 0.011
  35. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000.
    View in: PubMed
    Score: 0.011
  36. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7.
    View in: PubMed
    Score: 0.011
  37. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9.
    View in: PubMed
    Score: 0.011
  38. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage. 2010 Aug; 40(2):191-9.
    View in: PubMed
    Score: 0.011
  39. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer. 2010 Apr 15; 116(8):2053-63.
    View in: PubMed
    Score: 0.010
  40. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine. 2010 Apr; 12(4):421-30.
    View in: PubMed
    Score: 0.010
  41. Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer. 2011 Apr; 19(4):505-11.
    View in: PubMed
    Score: 0.010
  42. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 2010 Jan 01; 116(1):137-45.
    View in: PubMed
    Score: 0.010
  43. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
    View in: PubMed
    Score: 0.009
  44. Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage. 2009 Mar; 37(3):331-40.
    View in: PubMed
    Score: 0.009
  45. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
    View in: PubMed
    Score: 0.009
  46. Psychometric properties of the brief fatigue inventory in Greek patients with advanced cancer. J Pain Symptom Manage. 2008 Oct; 36(4):367-73.
    View in: PubMed
    Score: 0.009
  47. Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage. 2008 Sep; 36(3):259-67.
    View in: PubMed
    Score: 0.009
  48. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
    View in: PubMed
    Score: 0.009
  49. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer. 2007 Oct 01; 110(7):1629-40.
    View in: PubMed
    Score: 0.009
  50. People in pain: how do they seek relief? J Pain. 2007 Aug; 8(8):624-36.
    View in: PubMed
    Score: 0.009
  51. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(12):759-66.
    View in: PubMed
    Score: 0.008
  52. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006; 71(1-2):69-76.
    View in: PubMed
    Score: 0.008
  53. An urban community's preferences for hypothetical outcomes of analgesic pain treatment. J Pain Symptom Manage. 2006 Nov; 32(5):470-7.
    View in: PubMed
    Score: 0.008
  54. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol. 2006 Sep 20; 24(27):4485-91.
    View in: PubMed
    Score: 0.008
  55. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28.
    View in: PubMed
    Score: 0.008
  56. The association between symptom burdens and utility in Chinese cancer patients. Qual Life Res. 2006 Oct; 15(8):1427-38.
    View in: PubMed
    Score: 0.008
  57. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage. 2006 Jun; 31(6):542-52.
    View in: PubMed
    Score: 0.008
  58. Status of cancer pain in Hanoi, Vietnam: A hospital-wide survey in a tertiary cancer treatment center. J Pain Symptom Manage. 2006 May; 31(5):431-9.
    View in: PubMed
    Score: 0.008
  59. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006 Oct; 80(1):27-35.
    View in: PubMed
    Score: 0.008
  60. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006 Jan; 7(1):49-56.
    View in: PubMed
    Score: 0.008
  61. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006 May; 10(4):353-61.
    View in: PubMed
    Score: 0.008
  62. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol. 2005 Jun; 16(6):972-80.
    View in: PubMed
    Score: 0.007
  63. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage. 2005 Feb; 29(2):165-72.
    View in: PubMed
    Score: 0.007
  64. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004 Dec 15; 22(24):4918-25.
    View in: PubMed
    Score: 0.007
  65. Perceptions of analgesic use and side effects: what the public values in pain management. J Pain Symptom Manage. 2004 Nov; 28(5):460-73.
    View in: PubMed
    Score: 0.007
  66. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901.
    View in: PubMed
    Score: 0.007
  67. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004 Sep-Oct; 20(5):309-18.
    View in: PubMed
    Score: 0.007
  68. The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain. 2004 Sep-Oct; 20(5):357-62.
    View in: PubMed
    Score: 0.007
  69. The analgesic effects that underlie patient satisfaction with treatment. Pain. 2004 Jul; 110(1-2):480-7.
    View in: PubMed
    Score: 0.007
  70. Lessons learned from a multiple-dose post-operative analgesic trial. Pain. 2004 May; 109(1-2):103-9.
    View in: PubMed
    Score: 0.007
  71. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32.
    View in: PubMed
    Score: 0.007
  72. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology. 2004; 66(6):439-44.
    View in: PubMed
    Score: 0.007
  73. Pain and fatigue in community-dwelling adults. Pain Med. 2003 Sep; 4(3):231-7.
    View in: PubMed
    Score: 0.007
  74. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage. 2003 Aug; 26(2):748-59.
    View in: PubMed
    Score: 0.007
  75. Variations in patients' self-report of pain by treatment setting. J Pain Symptom Manage. 2003 May; 25(5):444-8.
    View in: PubMed
    Score: 0.006
  76. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage. 2003 May; 25(5):449-58.
    View in: PubMed
    Score: 0.006
  77. Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. J Natl Cancer Inst. 2023 04 11; 115(4):437-446.
    View in: PubMed
    Score: 0.006
  78. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr; 25(4):307-18.
    View in: PubMed
    Score: 0.006
  79. Patient-reported symptoms at discharge and risk of complications after gynecologic surgery. Int J Gynecol Cancer. 2023 02 06; 33(2):271-277.
    View in: PubMed
    Score: 0.006
  80. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Sci Rep. 2022 08 23; 12(1):14367.
    View in: PubMed
    Score: 0.006
  81. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002 Apr 15; 94(8):2295-304.
    View in: PubMed
    Score: 0.006
  82. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002 Mar 01; 20(5):1319-28.
    View in: PubMed
    Score: 0.006
  83. Impact of pain on self-rated health in the community-dwelling older adults. Pain. 2002 Jan; 95(1-2):75-82.
    View in: PubMed
    Score: 0.006
  84. Identification of Breast Cancer Survivors With High Symptom Burden. Cancer Nurs. 2022 Jul-Aug 01; 45(4):253-261.
    View in: PubMed
    Score: 0.006
  85. Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer. 2001 Sep 15; 92(6 Suppl):1725-32.
    View in: PubMed
    Score: 0.006
  86. Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery. Gynecol Oncol. 2021 04; 161(1):83-88.
    View in: PubMed
    Score: 0.006
  87. Greek brief pain inventory: validation and utility in cancer pain. Oncology. 2001; 60(1):35-42.
    View in: PubMed
    Score: 0.005
  88. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000 Oct 01; 89(7):1634-46.
    View in: PubMed
    Score: 0.005
  89. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.005
  90. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module. Jpn J Clin Oncol. 2020 Jul 09; 50(7):787-793.
    View in: PubMed
    Score: 0.005
  91. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer. JCO Oncol Pract. 2020 10; 16(10):e1151-e1160.
    View in: PubMed
    Score: 0.005
  92. Symptom burden and its functional impact in patients with "symptomatic" relapsed or refractory multiple myeloma. Support Care Cancer. 2021 Jan; 29(1):467-475.
    View in: PubMed
    Score: 0.005
  93. Minority cancer patients and their providers: pain management attitudes and practice. Cancer. 2000 Apr 15; 88(8):1929-38.
    View in: PubMed
    Score: 0.005
  94. Performance Measures Based on How Adults With Cancer Feel and Function: Stakeholder Recommendations and Feasibility Testing in Six Cancer Centers. JCO Oncol Pract. 2020 03; 16(3):e234-e250.
    View in: PubMed
    Score: 0.005
  95. Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs. 2020 08; 38(4):1166-1174.
    View in: PubMed
    Score: 0.005
  96. Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). East Mediterr Health J. 2019 Nov 25; 25(11):784-790.
    View in: PubMed
    Score: 0.005
  97. Validation of the Brief Pain Inventory in a Taiwanese population. J Pain Symptom Manage. 1999 Nov; 18(5):316-22.
    View in: PubMed
    Score: 0.005
  98. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):100-107.
    View in: PubMed
    Score: 0.005
  99. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage. 1999 Sep; 18(3):180-7.
    View in: PubMed
    Score: 0.005
  100. Patient-reported outcomes in light of supportive medications in treatment-na?ve lung cancer patients. Support Care Cancer. 2020 Apr; 28(4):1809-1816.
    View in: PubMed
    Score: 0.005
  101. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage. 2019 10; 58(4):662-671.
    View in: PubMed
    Score: 0.005
  102. Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study. J Med Internet Res. 2019 03 14; 21(3):e10348.
    View in: PubMed
    Score: 0.005
  103. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol. 2019 03; 152(3):492-500.
    View in: PubMed
    Score: 0.005
  104. Assessment of baseline symptom burden in treatment-na?ve patients with lung cancer: an observational study. Support Care Cancer. 2019 Sep; 27(9):3439-3447.
    View in: PubMed
    Score: 0.005
  105. The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage. 1999 Jan; 17(1):27-41.
    View in: PubMed
    Score: 0.005
  106. Cancer-Related Internet Use and Online Social Networking Among Patients in an Early-Phase Clinical Trials Clinic at a Comprehensive Cancer Center. JCO Clin Cancer Inform. 2018 12; 2:1-14.
    View in: PubMed
    Score: 0.005
  107. A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors. Cancer Med. 2018 11; 7(11):5457-5469.
    View in: PubMed
    Score: 0.005
  108. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. Lancet Oncol. 2018 09; 19(9):e459-e469.
    View in: PubMed
    Score: 0.005
  109. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study. Qual Life Res. 2018 06; 27(6):1563-1570.
    View in: PubMed
    Score: 0.005
  110. Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma. Qual Life Res. 2018 Apr; 27(4):979-985.
    View in: PubMed
    Score: 0.004
  111. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med. 1997 Nov 01; 127(9):813-6.
    View in: PubMed
    Score: 0.004
  112. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
    View in: PubMed
    Score: 0.004
  113. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D. Qual Life Res. 2017 08; 26(8):2067-2078.
    View in: PubMed
    Score: 0.004
  114. Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Ann Hematol. 2017 Jun; 96(6):977-985.
    View in: PubMed
    Score: 0.004
  115. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263.
    View in: PubMed
    Score: 0.004
  116. A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients. Support Care Cancer. 2017 06; 25(6):1809-1817.
    View in: PubMed
    Score: 0.004
  117. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial. Lancet Haematol. 2017 Feb; 4(2):e67-e74.
    View in: PubMed
    Score: 0.004
  118. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996 Oct; 67(2-3):267-73.
    View in: PubMed
    Score: 0.004
  119. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain. 1996 Oct; 67(2-3):407-16.
    View in: PubMed
    Score: 0.004
  120. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res. 2017 04; 26(4):913-921.
    View in: PubMed
    Score: 0.004
  121. Effects of oral morphine on cold pressor tolerance time and neuropsychological performance. Neuropsychopharmacology. 1996 Sep; 15(3):252-62.
    View in: PubMed
    Score: 0.004
  122. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer. 2016 Nov 15; 122(21):3401-3409.
    View in: PubMed
    Score: 0.004
  123. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr; 65(1):87-92.
    View in: PubMed
    Score: 0.004
  124. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1107-14.
    View in: PubMed
    Score: 0.004
  125. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. J Pain Symptom Manage. 2016 06; 51(6):1055-61.
    View in: PubMed
    Score: 0.004
  126. Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy. J Pain Symptom Manage. 2016 05; 51(5):832-8.
    View in: PubMed
    Score: 0.004
  127. Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. Blood Cancer J. 2016 Feb 12; 6:e396.
    View in: PubMed
    Score: 0.004
  128. Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study. Cancer. 2016 02 01; 122(3):438-46.
    View in: PubMed
    Score: 0.004
  129. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
    View in: PubMed
    Score: 0.004
  130. Patient-Reported Outcomes Accurately Measure the Value of an Enhanced Recovery Program in Liver Surgery. J Am Coll Surg. 2015 Dec; 221(6):1023-30.e1-2.
    View in: PubMed
    Score: 0.004
  131. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol. 2015 Oct; 117(1):132-8.
    View in: PubMed
    Score: 0.004
  132. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Support Care Cancer. 2016 Mar; 24(3):1327-37.
    View in: PubMed
    Score: 0.004
  133. Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study. Thyroid. 2015 Oct; 25(10):1085-90.
    View in: PubMed
    Score: 0.004
  134. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis. Biol Blood Marrow Transplant. 2016 Feb; 22(2):226-231.
    View in: PubMed
    Score: 0.004
  135. Whole head mapping of magnetic fields following painful electric finger shock. Brain Res Cogn Brain Res. 1995 Jul; 2(3):165-72.
    View in: PubMed
    Score: 0.004
  136. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg. 2015 Sep; 150(3):613-9.e2.
    View in: PubMed
    Score: 0.004
  137. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995 May; 61(2):277-284.
    View in: PubMed
    Score: 0.004
  138. Automated pain intervention for underserved minority women with breast cancer. Cancer. 2015 Jun 01; 121(11):1882-90.
    View in: PubMed
    Score: 0.004
  139. Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Support Care Cancer. 2015 Apr; 23(4):1157-68.
    View in: PubMed
    Score: 0.004
  140. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma. 2015 May; 56(5):1335-41.
    View in: PubMed
    Score: 0.004
  141. Socioeconomic status is associated with depressive severity among patients with advanced non-small-cell lung cancer: treatment setting and minority status do not make a difference. J Thorac Oncol. 2014 Oct; 9(10):1459-63.
    View in: PubMed
    Score: 0.004
  142. A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. Cancer Res. 2014 Nov 01; 74(21):5955-62.
    View in: PubMed
    Score: 0.004
  143. Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. J Clin Oncol. 2014 Oct 01; 32(28):3156-62.
    View in: PubMed
    Score: 0.004
  144. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26.
    View in: PubMed
    Score: 0.004
  145. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study. J Pain Symptom Manage. 2015 Jan; 49(1):117-25.
    View in: PubMed
    Score: 0.003
  146. Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study. Acta Oncol. 2014 Sep; 53(9):1173-9.
    View in: PubMed
    Score: 0.003
  147. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84.
    View in: PubMed
    Score: 0.003
  148. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994 Mar 03; 330(9):592-6.
    View in: PubMed
    Score: 0.003
  149. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014 Jan-Feb; 20(1):8-14.
    View in: PubMed
    Score: 0.003
  150. Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02. J Clin Oncol. 2014 Feb 01; 32(4):312-9.
    View in: PubMed
    Score: 0.003
  151. Screening for depressed mood in patients with cancer using the MD Anderson Symptom Inventory: investigation of a practical approach for the oncologist. J Oncol Pract. 2014 Mar; 10(2):e95-102.
    View in: PubMed
    Score: 0.003
  152. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer. 2013 Dec 01; 119(23):4188-95.
    View in: PubMed
    Score: 0.003
  153. Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer. 2013 Dec; 21(12):3497-507.
    View in: PubMed
    Score: 0.003
  154. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer. 2013 Oct; 13(5):325-34.
    View in: PubMed
    Score: 0.003
  155. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 01; 122(5):641-7.
    View in: PubMed
    Score: 0.003
  156. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1531-40.
    View in: PubMed
    Score: 0.003
  157. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol. 2013 Feb 05; 6:13.
    View in: PubMed
    Score: 0.003
  158. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv. 2013 Jun; 7(2):191-202.
    View in: PubMed
    Score: 0.003
  159. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res. 2013 Oct; 22(8):2143-50.
    View in: PubMed
    Score: 0.003
  160. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8.
    View in: PubMed
    Score: 0.003
  161. Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res. 2012 Jun 01; 18(11):3180-7.
    View in: PubMed
    Score: 0.003
  162. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 2012 Oct 15; 118(20):5026-37.
    View in: PubMed
    Score: 0.003
  163. Cancer pain in the marital system: a study of patients and their spouses. J Pain Symptom Manage. 1992 Feb; 7(2):87-93.
    View in: PubMed
    Score: 0.003
  164. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol. 2012 Apr; 13(4):395-402.
    View in: PubMed
    Score: 0.003
  165. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst. 2011 Dec 21; 103(24):1851-8.
    View in: PubMed
    Score: 0.003
  166. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):587-99.
    View in: PubMed
    Score: 0.003
  167. The effects of induced mood on laboratory pain. Pain. 1991 Jul; 46(1):105-111.
    View in: PubMed
    Score: 0.003
  168. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol. 2011 Sep; 22(9):2107-2112.
    View in: PubMed
    Score: 0.003
  169. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 2011 Jul 15; 117(14):3222-8.
    View in: PubMed
    Score: 0.003
  170. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage. 2011 Mar; 41(3):558-65.
    View in: PubMed
    Score: 0.003
  171. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer. 2011 Nov; 19(11):1753-60.
    View in: PubMed
    Score: 0.003
  172. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. J Pain Symptom Manage. 2010 Jul; 40(1):75-86.
    View in: PubMed
    Score: 0.003
  173. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2010 Apr; 39(4):721-33.
    View in: PubMed
    Score: 0.003
  174. The effects of distraction on responses to cold pressor pain. Pain. 1990 Apr; 41(1):109-114.
    View in: PubMed
    Score: 0.003
  175. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010 Aug; 24(6):968-74.
    View in: PubMed
    Score: 0.003
  176. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8.
    View in: PubMed
    Score: 0.003
  177. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009 Sep; 10(9):865-71.
    View in: PubMed
    Score: 0.002
  178. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):775-81.
    View in: PubMed
    Score: 0.002
  179. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer. 2008 Oct 15; 113(8):2102-9.
    View in: PubMed
    Score: 0.002
  180. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail. 2008 Aug; 14(6):497-507.
    View in: PubMed
    Score: 0.002
  181. Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory. Cancer Nurs. 2008 May-Jun; 31(3):E9-16.
    View in: PubMed
    Score: 0.002
  182. Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer. 2008 Apr 01; 112(7):1617-24.
    View in: PubMed
    Score: 0.002
  183. Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain. 2008 Mar; 135(1-2):175-86.
    View in: PubMed
    Score: 0.002
  184. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliat Med. 2007 Dec; 21(8):667-72.
    View in: PubMed
    Score: 0.002
  185. Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage. 2008 Jan; 35(1):95-102.
    View in: PubMed
    Score: 0.002
  186. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain. 2008 Jul 15; 137(2):276-285.
    View in: PubMed
    Score: 0.002
  187. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007 Aug; 7(2):151-60.
    View in: PubMed
    Score: 0.002
  188. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007 Jul; 15(7):891-6.
    View in: PubMed
    Score: 0.002
  189. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain. 2007 May; 23(4):287-99.
    View in: PubMed
    Score: 0.002
  190. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage. 2007 Feb; 33(2):180-8.
    View in: PubMed
    Score: 0.002
  191. Clinicians' practice and attitudes toward cancer pain management in Korea. Support Care Cancer. 2007 May; 15(5):463-9.
    View in: PubMed
    Score: 0.002
  192. Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 2):6209s-6212s.
    View in: PubMed
    Score: 0.002
  193. Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and Hispanics. J Pain. 2007 Jan; 8(1):75-84.
    View in: PubMed
    Score: 0.002
  194. Factors influencing physician management of cancer pain. Cancer. 1986 Aug 01; 58(3):796-800.
    View in: PubMed
    Score: 0.002
  195. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9.
    View in: PubMed
    Score: 0.002
  196. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr; 31(4):345-52.
    View in: PubMed
    Score: 0.002
  197. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005 Nov; 30(5):443-53.
    View in: PubMed
    Score: 0.002
  198. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005 Jun 01; 97(11):798-804.
    View in: PubMed
    Score: 0.002
  199. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47.
    View in: PubMed
    Score: 0.002
  200. Documentation of pain in comprehensive cancer centers in the United States: a preliminary analysis. J Natl Compr Canc Netw. 2004 Mar; 2(2):173-80.
    View in: PubMed
    Score: 0.002
  201. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004 Feb 07; 25(3):94-102.
    View in: PubMed
    Score: 0.002
  202. The relationship of mood state to the severity of clinical pain. Pain. 1984 Feb; 18(2):187-197.
    View in: PubMed
    Score: 0.002
  203. Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol. 2004 Jan; 34(1):37-42.
    View in: PubMed
    Score: 0.002
  204. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients. Oncology. 2004; 67(3-4):203-10.
    View in: PubMed
    Score: 0.002
  205. Emotional states and pain: intraindividual and interindividual measures of association. J Behav Med. 1983 Dec; 6(4):405-19.
    View in: PubMed
    Score: 0.002
  206. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003 Dec; 26(6):1093-104.
    View in: PubMed
    Score: 0.002
  207. The Indians have many terms for it: stuttering among the Bannock-Shoshoni. J Speech Hear Res. 1983 Jun; 26(2):315-8.
    View in: PubMed
    Score: 0.002
  208. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003 Feb; 25(2):106-17.
    View in: PubMed
    Score: 0.002
  209. [Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]. Med Clin (Barc). 2003 Jan 25; 120(2):52-9.
    View in: PubMed
    Score: 0.002
  210. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002 Nov; 24(5):517-25.
    View in: PubMed
    Score: 0.002
  211. The prevalence and severity of pain in cancer. Cancer. 1982 Nov 01; 50(9):1913-8.
    View in: PubMed
    Score: 0.002
  212. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002 Aug 15; 95(4):888-95.
    View in: PubMed
    Score: 0.002
  213. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer. 1999 Nov 01; 86(9):1848-55.
    View in: PubMed
    Score: 0.001
  214. Biofeedback in urology using urodynamics: preliminary observations. J Urol. 1979 Apr; 121(4):464-8.
    View in: PubMed
    Score: 0.001
  215. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 01; 85(5):1186-96.
    View in: PubMed
    Score: 0.001
  216. A brief cancer pain assessment tool in Japanese: the utility of the Japanese Brief Pain Inventory--BPI-J. J Pain Symptom Manage. 1998 Dec; 16(6):364-73.
    View in: PubMed
    Score: 0.001
  217. Movement disorders as a complication of acute hemiplegia of childhood. Am J Dis Child. 1977 Sep; 131(9):1009-10.
    View in: PubMed
    Score: 0.001
  218. Multicentre study of cancer pain and its treatment in France. BMJ. 1995 Apr 22; 310(6986):1034-7.
    View in: PubMed
    Score: 0.001
  219. Behavioral technics in the modification of spasmodic torticollis. Neurology. 1973 Nov; 23(11):1241-7.
    View in: PubMed
    Score: 0.001
  220. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993 Jul 15; 119(2):121-6.
    View in: PubMed
    Score: 0.001
  221. Modification of lip hypertonia in dysarthria using EMG feedback. J Speech Hear Disord. 1973 Feb; 38(1):131-40.
    View in: PubMed
    Score: 0.001
  222. Neurological and neuropsychological effects of botulinum toxin. Dis Nerv Syst. 1971 Oct; 32(10):702-6.
    View in: PubMed
    Score: 0.001
  223. Physiologic and psychobehavioral research in oncology. Cancer. 1991 Feb 01; 67(3 Suppl):813-22.
    View in: PubMed
    Score: 0.001
  224. MMPI profiles in exacerbation and remission of multiple sclerosis. Psychol Rep. 1970 Oct; 27(2):373-4.
    View in: PubMed
    Score: 0.001
  225. Petit mal evoked by arousal during sensory restriction. Arch Neurol. 1967 Sep; 17(3):324-30.
    View in: PubMed
    Score: 0.001
  226. Public attitudes toward cancer pain. Cancer. 1985 Nov 01; 56(9):2337-9.
    View in: PubMed
    Score: 0.000
  227. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983 Oct; 17(2):197-210.
    View in: PubMed
    Score: 0.000
  228. Neuropsychological patterns in multiple sclerosis. Dis Nerv Syst. 1970 Mar; 31(3):161-70.
    View in: PubMed
    Score: 0.000
  229. A case of voice-induced epilepsy treated by conditioning. Neurology. 1969 Apr; 19(4):325-31.
    View in: PubMed
    Score: 0.000
  230. Juvenile Huntington's chorea. Neurology. 1968 Mar; 18(3):217-24.
    View in: PubMed
    Score: 0.000
  231. A case of voice-induced epilepsy by conditioning. Neurology. 1968 Mar; 18(3):290.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.